D, S., S, H., N, M., B, Y., & J, G. (2024). Efficacy and safety of PD-1/PD-L1 and CTLA-4 immune checkpoint inhibitors in the treatment of advanced colorectal cancer: A systematic review and meta-analysis. Frontiers in immunology, 15, 1485303. https://doi.org/10.3389/fimmu.2024.1485303
Chicago Style (17th ed.) CitationD, Song, Hou S, Ma N, Yan B, and Gao J. "Efficacy and Safety of PD-1/PD-L1 and CTLA-4 Immune Checkpoint Inhibitors in the Treatment of Advanced Colorectal Cancer: A Systematic Review and Meta-analysis." Frontiers in Immunology 15 (2024): 1485303. https://doi.org/10.3389/fimmu.2024.1485303.
MLA (9th ed.) CitationD, Song, et al. "Efficacy and Safety of PD-1/PD-L1 and CTLA-4 Immune Checkpoint Inhibitors in the Treatment of Advanced Colorectal Cancer: A Systematic Review and Meta-analysis." Frontiers in Immunology, vol. 15, 2024, p. 1485303, https://doi.org/10.3389/fimmu.2024.1485303.